Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Dietary Lipid Induced Insulin Resistance
NCT02403284Phase 4Completed
- Sponsor
- Phoenix VA Health Care System
- Start
- Mar 2013
- Primary completion
- Apr 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of liraglutide in insulin resistance (IR), sponsored by Phoenix VA Health Care System. Started Mar 2013; status: completed.
02
Drugs
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT02403284.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02403284.